An observational study in Paroxysmal Atrial Fibrillation, sponsored by Deutsches Herzzentrum Muenchen. Completed at 1 site in Germany. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-07-25.
Sponsored by Deutsches Herzzentrum Muenchen · Observational
High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation: safety and acute procedural outcome
3,870 studies on the registry are indexed under Atrial Fibrillation; 924 are open to participants now.
This study's enrollment of 204 is below the median of 300 across 1,363 observational studies indexed under Atrial Fibrillation.
Browse Atrial Fibrillation studies →Deutsches Herzzentrum Muenchen is the lead sponsor of 112 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with documented paroxysmal atrial fibrillation, not previously treated by left atrial catheter ablation
Exclusion Criteria:
Procedure: High power short duration ablation
Procedure: High power short duration ablation
Pulmonary vein isolation by high power short duration radiofrequency catheter ablation
Number of reconnected pulmonary veins 20 minutes after ablation in comparison of both ablation groups
Time frame: Acute endpoint
Time to first documented recurrence of atrial fibrillation after a 6-week blanking period.
Time frame: 12 months after ablation
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Deutsches Herzzentrum Muenchen